Small molecules & peptides
DOTA-TATE acetate (GMP)
Precursor for radiolabelled DOTA-[Tyr3]octreotate
DOTA-[Tyr3]-Octreotate, DOTA-[Tyr3, Thr8]-Octreotide
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, cyclic disulfide; DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-; Supplied as acetate salt
Quality
GMP Product
Characteristics
Molar mass 1435.63
CAS RN [177943-89-4]
- Colorless to off-white solid
- Tested for bioburden and bacterial endotoxins.
Literature
De Jong M. et al. Combination Radionuclide Therapy Using ¹⁷⁷Lu- and ⁹⁰Y-Labeled Somatostatin Analogs. J. Nucl. Med., 2005, 46,13S
Valkema R. et al. Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ⁹⁰Y-DOTA0,Tyr3-Octreotide and ¹⁷⁷Lu-DOTA0,Tyr3-Octreotate. J. Nucl. Med. 2005, 46, 8
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/f22f1abb-be17-42fb-9f1a-13c79a086714 | Chemicals | Product No.: 9777 |
Product was added